Enhancing Laboratory Efficiency And Accelerating Time To Market With The Cydem VT System: From Minipool To Top Clone Screening

This content is brought to you by Beckman Coulter, a Danaher Operating Company.

Cell line development teams need to evaluate large numbers of candidates quickly without overlooking clones with strong production potential. In collaborative testing by Beckman Coulter Life Sciences and Cytiva, the Cydem VT Automated Clone Screening System showed strong alignment with established manual workflows while supporting faster, more informed decisions. The system identified 95% of the same top minipools and 60% of the same top clones selected through manual screening, while also uncovering promising clones the traditional process missed.

Explore how automated screening can shorten CLD timelines, reduce downstream risk, and improve confidence in clone selection.